Use of the Iron Chelator Deferiprone to Restore Function in BAL Fluid Macrophages in Smoking and Chronic Obstructive Pulmonary Disease

Am J Respir Cell Mol Biol. 2023 Apr;68(4):458-462. doi: 10.1165/rcmb.2022-0372LE.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Deferiprone / pharmacology
  • Deferiprone / therapeutic use
  • Humans
  • Iron Chelating Agents / pharmacology
  • Iron Chelating Agents / therapeutic use
  • Iron*
  • Macrophages
  • Pulmonary Disease, Chronic Obstructive* / drug therapy
  • Pyridones / pharmacology
  • Pyridones / therapeutic use
  • Smoking / adverse effects

Substances

  • Iron
  • Deferiprone
  • Iron Chelating Agents
  • Pyridones